UW-Madison researchers are part of a five-year, $29 million National Institutes of Health grant using gene editing to develop drugs for two rare diseases that cause blindness.
Office of Strategic Communication
UW-Madison researchers are part of a five-year, $29 million National Institutes of Health grant using gene editing to develop drugs for two rare diseases that cause blindness.